Gp350-anchored extracellular vesicles: promising vehicles for delivering therapeutic drugs of B cell malignancies

Although chimeric antigen receptor-modified (CAR) T cell therapy has been successfully applied in the treatment of acute B lymphocytic leukemia, its effect on Burkitt lymphoma (BL) and chronic B lymphocytic leukemia (B-CLL) is unsatisfactory. Moreover, fatal side effects greatly impede CAR T cell ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiu, Huiqing, Nan, Xi, Guo, Danfeng, Wang, Jiaoli, Li, Jiahui, Peng, Yanmei, Xiong, Guirun, Wang, Shibo, Wang, Changjun, Zhang, Gensheng, Yang, Yunshan, Cai, Zhijian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shenyang Pharmaceutical University 2022
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237600/
https://www.ncbi.nlm.nih.gov/pubmed/35782327
http://dx.doi.org/10.1016/j.ajps.2022.03.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237600/
https://www.ncbi.nlm.nih.gov/pubmed/35782327
http://dx.doi.org/10.1016/j.ajps.2022.03.004

Ejemplares similares